Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Sep
26
2022
Biogen Inc. Agrees to Pay $900 Million to Settle Allegations Related to Improper Physician Payments The U.S. Department of Justice
Sep
26
2022
Issue-Spotting Hospital Activities that May Trigger FDA Regulatory Oversight [PODCAST] K&L Gates
Sep
26
2022
Federal Appeals Court Upholds USDA Decision Not to Ban “Organic” Label for Hydroponics Keller and Heckman LLP
Sep
24
2022
413 Pounds of Concealed Marijuana Intercepted by Cincinnati CBP U.S. Customs and Border Protection
Sep
23
2022
Ongoing Foodborne Illness Outbreaks Increasing Keller and Heckman LLP
Sep
22
2022
USDA Issues Regulatory Status Response re GM Tomatoes Keller and Heckman LLP
Sep
22
2022
Prop 65 Regulatory Update for the Cannabis Industry: Tailored Warnings Become Effective October 1, 2022 with a 1-Year Grace Period for Compliance Squire Patton Boggs (US) LLP
Sep
22
2022
China Publishes Draft Standards for Food Additives Keller and Heckman LLP
Sep
21
2022
In One Day, California Governor Signs Into Law Ten Cannabis Bills, Including Authorization for Interstate Commerce Sheppard, Mullin, Richter & Hampton LLP
Sep
21
2022
FDA Publishes Internal Evaluation of Infant Formula Response Keller and Heckman LLP
Sep
20
2022
Pharmaceutical Manufacturer Pays $7.9 Million to Resolve Allegations that it Caused the Submission of Over-the-Counter Drugs to Medicare Part D Mintz
Sep
20
2022
Biden's Executive Order Focusing on Biotechnology Offers Opportunities for AgTech Industry ArentFox Schiff LLP
Sep
20
2022
“Made with Real Butter” Claim Challenged Keller and Heckman LLP
Sep
20
2022
California Enacts Law Prohibiting Employment Discrimination Based On Off-Duty Marijuana Use, Effective 2024 Jackson Lewis P.C.
Sep
19
2022
New California Bill Protects Employees’ Off-Duty Marijuana Use
Sep
19
2022
Court Mostly Upholds the National Bioengineered Food Disclosure Standard While Remanding USDA’s Text Message Disclosure Decision Keller and Heckman LLP
Sep
19
2022
US Department of Labor Awards $3M to Support Project to Improve Working Conditions in Bangladesh, Focused on Labor Rights Abuses in Three Cities U.S. Department of Labor
Sep
19
2022
High Times Ahead for Employers in California Jackson Lewis P.C.
Sep
16
2022
NJ Cannabis Regulatory Commission Publishes Guidance For Employers To Address Marijuana Impairment Jackson Lewis P.C.
Sep
16
2022
Whistleblower Receives $11 Million for Reporting Pharmaceutical Fraud Tycko & Zavareei LLP
Sep
15
2022
Defense Strategies and FAQs if Your Board of Pharmacy is Investigating You Oberheiden P.C.
Sep
15
2022
California Expands FEHA to Include Off The Job Cannabis Use Sheppard, Mullin, Richter & Hampton LLP
Sep
15
2022
FDA Announces 2022 Leafy Green Sampling Keller and Heckman LLP
Sep
15
2022
USDA Publishes ANPR on Inert Ingredients in Pesticides for Organic Production Bergeson & Campbell, P.C.
Sep
14
2022
EUON Publishes Nanopinion on the Transportation of Nanoparticles across the Blood-Brain Barrier Bergeson & Campbell, P.C.
Sep
14
2022
BIS Proposes Designating Automated Peptide Synthesizers as a Section 1758 Technology Squire Patton Boggs (US) LLP
Sep
14
2022
New Jersey Cannabis Regulatory Commission Releases Interim Drug Testing Guidance Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Sep
14
2022
FDA Updates Prior Notice of Imported Food Draft Guidance Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins